BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25305151)

  • 1. Performance assessment of the BD MAX Cdiff assay in comparison to Xpert C. difficile assay in a setting with very low prevalence of toxigenic Clostridium difficile PCR ribotype 027.
    Chiang D; Ng S; La MV; Jureen R; Lin RT; Teo JW
    Anaerobe; 2014 Dec; 30():156-8. PubMed ID: 25305151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
    Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
    J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Cepheid Xpert C. difficile/Epi and meridian bioscience illumigene C. difficile assays for detecting Clostridium difficile ribotype 033 strains.
    Androga GO; McGovern AM; Elliott B; Chang BJ; Perkins TT; Foster NF; Riley TV
    J Clin Microbiol; 2015 Mar; 53(3):973-5. PubMed ID: 25520452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples.
    Verhoeven PO; Carricajo A; Pillet S; Ros A; Fonsale N; Botelho-Nevers E; Lucht F; Berthelot P; Pozzetto B; Grattard F
    J Microbiol Methods; 2013 Jul; 94(1):58-60. PubMed ID: 23643507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Verigene Clostridium difficile, Simplexa C. difficile Universal Direct, BD MAX Cdiff, and Xpert C. difficile assays for the detection of toxigenic C. difficile.
    Gilbreath JJ; Verma P; Abbott AN; Butler-Wu SM
    Diagn Microbiol Infect Dis; 2014 Sep; 80(1):13-8. PubMed ID: 25027069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens.
    Putsathit P; Morgan J; Bradford D; Engelhardt N; Riley TV
    Pathology; 2015 Feb; 47(2):165-8. PubMed ID: 25551308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect of strain type on detection of toxigenic Clostridium difficile by glutamate dehydrogenase and polymerase chain reaction.
    Goldenberg SD; Gumban M; Hall A; Patel A; French GL
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):417-9. PubMed ID: 21683272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of BD Max Cdiff and GenomEra C. difficile molecular assays for detection of toxigenic Clostridium difficile from stools in conventional sample containers and in FecalSwabs.
    Hirvonen JJ; Kaukoranta SS
    Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):1005-9. PubMed ID: 25616552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: a double-edged sword.
    Williamson DA; Basu I; Freeman J; Swager T; Roberts SA
    Am J Infect Control; 2013 Mar; 41(3):270-2. PubMed ID: 22939418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C. difficile PCR-ribotype 023 might go undetected when using ChromId C. difficile agar.
    Reigadas E; Alcalá L; Marín M; Martín A; Bouza E
    Anaerobe; 2017 Apr; 44():34-35. PubMed ID: 28108388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of the Meridian Illumigene™ loop-mediated amplification assay and the Gen Probe ProGastro™ Cd polymerase chain reaction assay for the direct detection of toxigenic Clostridium difficile from fecal samples.
    Doing KM; Hintz MS
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):8-13. PubMed ID: 22015321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 3 automated real-time PCR (Xpert C. difficile assay, BD MAX Cdiff, and IMDx C. difficile for Abbott m2000 assay) for detecting Clostridium difficile toxin gene compared to toxigenic culture in stool specimens.
    Yoo J; Lee H; Park KG; Lee GD; Park YG; Park YJ
    Diagn Microbiol Infect Dis; 2015 Sep; 83(1):7-10. PubMed ID: 26081240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-laboratory comparison of two molecular methods for the detection of toxigenic Clostridium difficile.
    Halstead DC; Abid J; Sloan L; Meza D; Ramsey-Walker D; Hata DJ
    J Infect Dev Ctries; 2016 Jan; 10(1):62-7. PubMed ID: 26829538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of imported Clostridium difficile PCR-ribotype 027 infection within the Czech Republic which has a high prevalence of C. difficile ribotype 176.
    Krutova M; Nyc O; Kuijper EJ; Geigerova L; Matejkova J; Bergerova T; Arvand M
    Anaerobe; 2014 Dec; 30():153-5. PubMed ID: 25300750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type.
    René P; Frenette CP; Schiller I; Dendukuri N; Brassard P; Fenn S; Loo VG
    Diagn Microbiol Infect Dis; 2012 May; 73(1):94-6. PubMed ID: 22424900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.
    Dalpke AH; Hofko M; Zorn M; Zimmermann S
    J Clin Microbiol; 2013 Jun; 51(6):1906-8. PubMed ID: 23515539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Xpert C. difficile, BD MAX Cdiff, IMDx C. difficile for Abbott m2000, and Illumigene C. difficile Assays for Direct Detection of Toxigenic Clostridium difficile in Stool Specimens.
    Shin BM; Yoo SM; Shin WC
    Ann Lab Med; 2016 Mar; 36(2):131-7. PubMed ID: 26709260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First genotypic characterization of toxigenic Clostridioides difficile in Lithuanian hospitals reveals the prevalence of the hypervirulent ribotype 027/ST1.
    Tratulyte S; Miciuleviciene J; Kuisiene N
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1953-1959. PubMed ID: 31327067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two commercial molecular tests for the detection of Clostridium difficile in the routine diagnostic laboratory.
    Zidarič V; Kotnik Kevorkijan B; Oresic N; Janezic S; Rupnik M
    J Med Microbiol; 2011 Aug; 60(Pt 8):1131-1136. PubMed ID: 21372187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multiplex, internally controlled real-time PCR assay for detection of toxigenic Clostridium difficile and identification of hypervirulent strain 027/ST-1.
    Hoegh AM; Nielsen JB; Lester A; Friis-Møller A; Schønning K
    Eur J Clin Microbiol Infect Dis; 2012 Jun; 31(6):1073-9. PubMed ID: 21938539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.